Nanoparticle formulation of mycophenolate mofetil achieves enhanced efficacy against hepatocellular carcinoma by targeting tumour‐associated fibroblast-Reference-Cited by-同舟云学术

Nanoparticle formulation of mycophenolate mofetil achieves enhanced efficacy against hepatocellular carcinoma by targeting tumour‐associated fibroblast

Published:2021-03-13 Issue:7 Volume:25 Page:3511-3523
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Yang Zhentao¹²³⁴,Zhang Liang¹²³⁴,Zhu Hai¹²³⁴,Zhou Ke¹²³⁴,Wang Hangxiang¹²³⁴,Wang Yuchen²³⁴,Su Rong²³⁴,Guo Danjing²³⁴,Zhou Lin¹²³⁴,Xu Xiao¹²³⁴,Song Penghong¹²³⁴^ORCID,Zheng Shusen¹²³⁴^ORCID,Xie Haiyang¹²³⁴

Affiliation:

1. Division of Hepatobiliary and Pancreatic Surgery Department of Surgery First Afliated Hospital School of Medicine Zhejiang University Hangzhou China

2. NHC Key Laboratory of Combined Multi‐organ Transplantation Hangzhou China

3. Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer Chinese Academy of Medical Sciences (2019RU019) Hangzhou China

4. Key Laboratory of Organ Transplantation Hangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16434

Reference42 articles.

1. Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival

2. Hepatocellular Carcinoma